NewcelX updates presentation to highlight diabetes program collaboration Apr 20, 2026 07:38AM
NewcelX raises $1.35 million in equity financing at 30% premium Apr 1, 2026 07:25AM
NewcelX publishes peer-reviewed study on Mazindol ER therapy Feb 12, 2026 07:01AM
NewcelX patent application published in China for neurological drugs Dec 11, 2025 07:02AM
NewcelX CEO outlines clinical trial plans for neurodegenerative therapies Nov 4, 2025 07:01AM


Oct 30, 2025 04:16PM NLS Pharmaceutics and Kadimastem complete merger as NewcelX